中文 | EN | TEL:+86 (0)27 6502 2930

Position:Home > News > - Company News  News

  • +86 (0)27 6502 2930
  • bd@healthcare-bio.com
  • No. 666, Gaoxin Boulevard, Optics Valley Biolake, Building B6, 4/5F. Wuhan, Hubei, 430075, PR of China.

Wuhan HealthCare Biotech Co., Ltd.

Mirax Corporation (South Korea) General Manager visited

satisfactorily Wuhan HealthCare Biotechnology Co., Ltd.

 

Arrived in Wuhan in the afternoon of the 29 March 2018, and welcomed by Mr. Lambert Nyobe (Manager, BD, Wuhan HealthCare Biotech) and Mr. Huoran (Manager, Medical Department, Wuhan HealthCare Biotech), South Korea Mirax Corporation General Manager Mr. SJ. Bae and Ms. Min Grace (Technical Director) during three (3) days inspected thoroughly Wuhan HealthCare Biotech Co., Ltd. facility and led as part of the visit menu comparative experiments of products from famous brand against Wuhan HealthCare Biotech Co., Ltd. ones. At the end of the second day of their visit during the last round of cooperation talks between the two parties, as a synthesis of the two days activities, Mr. Bae expressed his high satisfaction on Wuhan HealthCare Biotech Co., Ltd. product excellent quality and results obtained from our FISH fully automated pretreatment instrument TL 101 and our FISH probes HER-2 and ALK that were part of the tests led. The road already being paved, the next steps are the introduction of Wuhan HealthCare Biotech Co., Ltd. product in South Korea market properly. Mr. Bae and Ms. Min left Wuhan on the 31 March 2018 filled with satisfaction of the mission accomplished.

 

Images of the visit